Effects of sufentanil and NMDA antagonists on a C-fibre reflex in the rat

被引:8
作者
Adam, F
Gairard, AC
Chauvin, M
Le Bars, D
Guirimand, F
机构
[1] INSERM, U161, Unite Rech Physiopharmacol Syst Nerveux, Paris, France
[2] Hop Ambroise Pare, Dept Anesthesie Reanimat, Boulogne, France
关键词
nociception; C-fibre reflex; sufentanil; NMDA receptor antagonists; obex-transection;
D O I
10.1038/sj.bjp.0704148
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The effects of intravenous sufentanil and pre-administration of N-methyl-D-aspartate (NMDA) receptor antagonists were tested on a reflex triggered by C-fibre activation. The reflex was elicited by electrical stimulation of the sural nerve and recorded from the ipsilateral biceps femoris muscle in halothane anaesthetized rats either (1) with an intact neuraxis or (2) in which the brain had previously been transected at the level of the obex. 2 All four doses of sufentanil (0.33, 0.6, 1 and 2 mug kg(-1)) elicited a depression of the reflex in a dose-dependent manner. However, following the expected depression, all doses of sufentanil elicited both facilitation of the reflex and tonic inter-stimulus discharges. 3 The C-fibre reflex was not modified following intravenous ketamine (1 mg kg(-1)) or (+)-HA966 (5 or 10 mg kg(-1)) but, when administered 5 min before sufentanil, these drugs enhanced both the extent and the duration of the depression and strongly reduced the facilitations. 4 In the obex-transected rats, the depressive effect of 1 mug kg(-1) sufentanil increased, while the facilitation of the C-fibre reflex and the tonic inter-stimulus discharges disappeared. Preadministration of 10 mg kg-' (+)-HA966 reinforced and prolonged the depressive effect of sufentanil. 5 These results extend previous studies suggesting the involvement of NMDA receptors in the spinal transmission of nociceptive signals. They illustrate the potential of spinal NMDA receptor blockade to both enhance the analgesic, and prevent the pro-nociceptive, effects of sufentanil.
引用
收藏
页码:1013 / 1022
页数:10
相关论文
共 44 条
[21]   Ketamine: Its mechanism(s) of action and unusual clinical uses [J].
Hirota, K ;
Lambert, DG .
BRITISH JOURNAL OF ANAESTHESIA, 1996, 77 (04) :441-444
[22]   Concomitant administration of morphine and an N-methyl-D-aspartate receptor antagonist profoundly reduces inflammatory evoked spinal c-fos expression [J].
Honore, P ;
Chapman, V ;
Buritova, J ;
Besson, JM .
ANESTHESIOLOGY, 1996, 85 (01) :150-160
[23]   DIFFERENTIAL MODULATION OF KAPPA-OPIOID AND MU-OPIOID ANTINOCICEPTION BY THE GLYCINE/NMDA RECEPTOR AGONIST D-SERINE [J].
HUNTER, JC ;
ATWAL, P ;
WOODRUFF, GN ;
SINGH, L .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 (04) :1002-1003
[24]   Comparison of morphine and morphine with ketamine for postoperative analgesia [J].
Javery, KB ;
Ussery, TW ;
Steger, HG ;
Colclough, GW .
CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 1996, 43 (03) :212-215
[25]   THE GLYCINE SITE OF THE NMDA RECEPTOR - 5 YEARS ON [J].
KEMP, JA ;
LEESON, PD .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1993, 14 (01) :20-25
[26]   MAGNITUDE OF ACUTE TOLERANCE TO OPIOIDS IS NOT RELATED TO THEIR POTENCY [J].
KISSIN, I ;
BROWN, PT ;
BRADLEY, EL .
ANESTHESIOLOGY, 1991, 75 (05) :813-816
[27]   SPECIFIC ACTION OF NARCOTICS ON REFLEX ACTIVATION OF RAT ALPHA-MOTONEURONES [J].
KUSCHINSKY, K ;
ROPTE, H ;
MESEKE, R ;
CREMER, H ;
SONTAG, KH .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1977, 296 (03) :249-254
[28]   Acute tolerance associated with a single opiate administration:: Involvement of N-methyl-D-aspartate-dependent pain facilitatory systems [J].
Larcher, A ;
Laulin, JP ;
Celerier, E ;
Le Moal, M ;
Simonnet, G .
NEUROSCIENCE, 1998, 84 (02) :583-589
[29]   DOES SYSTEMIC MORPHINE INCREASE DESCENDING INHIBITORY CONTROLS OHORN NEURONS INVOLVED IN NOCICEPTION [J].
LEBARS, D ;
GUILBAUD, G ;
CHITOUR, D ;
BESSON, JM .
BRAIN RESEARCH, 1980, 202 (01) :223-228
[30]   [H-3]-LABELED SUFENTANIL, A SUPERIOR LIGAND FOR MU-OPIATE RECEPTORS - BINDING-PROPERTIES AND REGIONAL DISTRIBUTION IN RAT-BRAIN AND SPINAL-CORD [J].
LEYSEN, JE ;
GOMMEREN, W ;
NIEMEGEERS, CJE .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1983, 87 (2-3) :209-225